Jubilant Pharmova Limited has announced the appointment of Arun Kumar Sharma as its new Chief Financial Officer (CFO), effective 1st October 2025. With more than three decades of experience in corporate finance and business transformation, Sharma will take on a pivotal leadership role to strengthen the company’s financial strategy and global operations.
Over his career, Sharma has developed extensive expertise in corporate finance, global treasury, investor relations, risk management, financial restructuring, insurance, capex control, and large-scale transformation programs. His appointment reflects Jubilant Pharmova’s continued focus on financial stability, transparency, and long-term growth.
Sharma is not new to the Jubilant Bhartia Foundation Group, having served in several critical leadership capacities. His previous roles include CFO at Jubilant Pharma Holdings Inc. USA, CFO of Jubilant Lifesciences (Chemical Business), and other key finance leadership positions within Jubilant Pharmova. Across these assignments, he has played a decisive role in driving both financial discipline and operational growth, contributing to the group’s performance in highly competitive global markets.
In addition to his long association with Jubilant, Sharma’s professional journey also spans leadership roles at Jubilant Life Sciences Ltd., Escorts Kubota Limited, and Gujral Mohan & Associates. Throughout these roles, he has been deeply involved in mergers and acquisitions, treasury management, corporate restructuring, and financial planning, underscoring his versatility as a finance leader.
The company highlighted that Sharma’s appointment comes at a crucial time, as Jubilant Pharmova navigates new opportunities and challenges in the global pharmaceutical and life sciences sector. His proven ability to build investor confidence, manage financial risk, and lead complex corporate finance initiatives is expected to support the company’s growth trajectory in the coming years.
By entrusting the CFO role to a seasoned finance executive with extensive knowledge of both domestic and international markets, Jubilant Pharmova is reinforcing its commitment to robust financial governance and strategic business leadership. Sharma’s return to a key leadership role within the group signals continuity as well as renewed focus on innovation and financial excellence.
